XML 66 R52.htm IDEA: XBRL DOCUMENT v3.22.0.1
Business Segment Information (Tables)
12 Months Ended
Dec. 31, 2021
Segment Reporting [Abstract]  
Schedule of revenue, operating income and total assets by reportable segment
Selected reportable segment information is presented below (in millions):
    
2021
    
2020
    
2019
 
Revenue:
                          
BSI Life Science
   $ 1,510.6      $ 1,253.9      $ 1,244.9  
BSI N
ano
     697.5        556.1        632.7  
BEST
     223.8        189.5        209.9  
Eliminations (a)
     (14.0      (12.0      (14.9
    
 
 
    
 
 
    
 
 
 
Total revenue
   $ 2,417.9      $ 1,987.5      $ 2,072.6  
    
 
 
    
 
 
    
 
 
 
Operating Income:
                          
BSI Life Science
   $ 385.4      $ 273.8      $ 290.3  
BSI N
ano
     73.4        23.6        40.4  
BEST
     22.2        6.2        16.4  
Corporate, eliminations and other (b)
     (67.7
     (55.3
  
  (46.2
    
 
 
    
 
 
    
 
 
 
Total operating income
   $ 413.3      $ 248.3      $ 300.9  
    
 
 
    
 
 
    
 
 
 
 
(a)
Represents product and service revenue between reportable segments.
(b)
Represents corporate costs and eliminations not allocated to the reportable segments.
Total assets by segment are as follows (in millions):
 
    
2021
    
2020
 
Assets:
                 
BSI Life Science, BSI N
ano
 & Corporate
   $ 3,560.5      $ 2,964.5  
BEST
     97.9        88.7  
Eliminations and other (a)
     (8.4      (4.2
    
 
 
    
 
 
 
Total assets
   $ 3,650.0      $ 3,049.0  
    
 
 
    
 
 
 
 
(a)
Assets not allocated to the reportable segments and eliminations of intercompany transactions.
Summary of capital expenditures and depreciation and amortization by segment
Total capital expenditures and depreciation and amortization by segment are presented below (in millions):
 
    
2021
    
2020
    
2019
 
Capital Expenditures:
                          
BSI Life Science
   $ 61.3      $ 59.1      $ 44.4  
BSI N
ano
     16.8        10.6        18.5  
Corporate
     4.7        17.4        4.7  
BEST
     9.2        10.1        5.4  
    
 
 
    
 
 
    
 
 
 
Total capital expenditures
   $ 92.0      $ 97.2      $ 73.0  
    
 
 
    
 
 
    
 
 
 
Depreciation and Amortization:
                          
BSI Life Science
   $ 41.1      $ 35.0      $ 30.5  
BSI
N
ano
     37.4        35.7        35.9  
Corporate
     4.3        4.0        3.8  
BEST
     6.3        5.7        5.4  
    
 
 
    
 
 
    
 
 
 
Total depreciation and amortization
   $ 89.1      $ 80.4      $ 75.6  
    
 
 
    
 
 
    
 
 
 
Schedule of revenue and property, plant and equipment, net by geographical area
Revenue and long-lived assets (including property, plant and equipment, net and operating lease right of use assets) by geographical area are as follows (in millions):

 
 
  
2021
 
  
2020
 
  
2019
 
Revenue:
                          
United States
   $ 601.0      $ 455.9      $ 529.8  
Germany
     262.6        244.9        213.6  
Rest of Europe
     658.1        519.8        505.2  
Asia Pacific
     729.1        629.1        651.0  
Other
     167.1        137.8        173.0  
    
 
 
    
 
 
    
 
 
 
Total revenue
   $ 2,417.9      $ 1,987.5      $ 2,072.6  
    
 
 
    
 
 
    
 
 
 
 
 
  
2021
 
  
2020
 
  
2019
 
Long-lived assets:
  
  
  
United States
  
$
51.3     
$
61.3     
$
53.2  
Germany
     244.0     
 
227.8     
 
175.1  
Rest of Europe
     141.5     
 
144.7     
 
118.3  
Asia Pacific
     22.6     
 
22.1     
 
16.4  
Other
     6.6     
 
7.1     
 
8.7  
    
 
 
    
 
 
    
 
 
 
Total long-lived assets
  
$
466.0     
$
463.0     
$
371.7